Disease State Differentiation and Identification of Tuberculosis Biomarkers via Native Antigen Array Profiling

Mark J. Sartain, Richard A. Slayden, Krishna K. Singh, Suman Laal, John T. Belisle

Molecular & Cellular Proteomics · 2006 · 103 citations · 35 references

DOIFull text

Open access

Concepts

Abstract

A critical element of tuberculosis control is early and sensitive diagnosis of infection and disease. Our laboratories recently showed that different stages of disease were distinguishable via two-dimensional Western blot analyses of Mycobacterium tuberculosis culture filtrate proteins. However, this methodology is not suitable for high throughput testing. Advances in protein microarray technology provide a realistic mechanism to screen a large number of serum samples against thousands of proteins to identify biomarkers of disease states. Techniques were established for separation of native M. tuberculosis cytosol and culture filtrate proteins, resulting in 960 unique protein fractions that were used to generate protein microarrays. Evaluation of serological reactivity from 42 patients in three tuberculosis disease states and healthy purified protein derivative-positive individuals demonstrated that human immunodeficiency virus (HIV)-negative cavitary and noncavitary tuberculosis (TB) patients’ sera recognized 126 and 59 fractions, respectively. Sera from HIV patients coinfected recognized fractions of recognized patients’ sera and were unique to disease of fractions recognized cavitary and noncavitary patients’ sera and proteins and to cavitary and of human tuberculosis were A critical element of tuberculosis control is early and sensitive diagnosis of infection and disease. Our laboratories recently showed that different stages of disease were distinguishable via two-dimensional Western blot analyses of Mycobacterium tuberculosis culture filtrate proteins. However, this methodology is not suitable for high throughput testing. Advances in protein microarray technology provide a realistic mechanism to screen a large number of serum samples against thousands of proteins to identify biomarkers of disease states. Techniques were established for separation of native M. tuberculosis cytosol and culture filtrate proteins, resulting in 960 unique protein fractions that were used to generate protein microarrays. Evaluation of serological reactivity from 42 patients in three tuberculosis disease states and healthy purified protein derivative-positive individuals demonstrated that human immunodeficiency virus (HIV)-negative cavitary and noncavitary tuberculosis (TB) patients’ sera recognized 126 and 59 fractions, respectively. Sera from HIV patients coinfected recognized fractions of recognized patients’ sera and were unique to disease of fractions recognized cavitary and noncavitary patients’ sera and proteins and to cavitary and of human tuberculosis were that of tuberculosis (TB) used culture filtrate human immunodeficiency M. protein purified protein used culture filtrate human immunodeficiency M. protein purified protein is and that is that of for a sensitive to control of a to of in in that to high of and and for of a for to disease and and patients coinfected human immunodeficiency virus from laboratories that provide high and used in of tuberculosis in human immunodeficiency virus to of Mycobacterium to of Mycobacterium of of human to culture filtrate of Mycobacterium of culture filtrate of Mycobacterium of serum and for diagnosis of of Mycobacterium tuberculosis recognized of Mycobacterium tuberculosis protein and this reactivity disease of tuberculosis in human immunodeficiency virus to of Mycobacterium of human to culture filtrate of Mycobacterium of culture filtrate of Mycobacterium of Mycobacterium tuberculosis recognized of Mycobacterium tuberculosis protein and of in tuberculosis However, a of patients’ serological reactivity to a large of Mycobacterium tuberculosis is to reactivity of proteins of in a high throughput protein for a M. M. A microarray for a for of and of protein for and serum a of from to of against of to and human for were in microarray of in and technology to microarray for to and virus M. to infection and thousands of a and for of to this methodology is and of sera from a large number of of a to a protein microarray native proteins were A separation to native proteins in cytosol and culture filtrate of in 960 protein fractions from protein fractions were to and sera from purified protein derivative-positive healthy cavitary noncavitary and and resulting analyses two-dimensional that a of is recognized early in disease proteins for cavitary patients were and were of from a to of culture in of Mycobacterium tuberculosis culture filtrate proteins two-dimensional and culture from and to generate culture filtrate proteins of of of of of Mycobacterium were three and of of in of and and a resulting of and for to cytosol of and M. of Mycobacterium and against a protein of cytosol and were protein of protein of and proteins of and proteins were 42 and and and respectively. proteins were for protein were in and of were against a and protein were of and and were to for fractions were to and to were a of of a of a protein fractions were and were and fractions of protein were fractions were fractions were to and to and proteins were of fractions were in a and in of and protein were Sera and from of individuals were of individuals were from is of Mycobacterium individuals were from and were not were of of patients disease of patients were individuals were to of of for were patients from in were to of for of patients were were of of patients from of patients of cavitary patients were to to of in of tuberculosis in human immunodeficiency virus to of Mycobacterium of culture filtrate of Mycobacterium patients were to of of for were individuals from sera were to to proteins to of Mycobacterium of and sera against proteins were from and of and were used for microarray analyses and and sera and of of to and in of protein were to and of to and a microarray proteins, native protein and fractions were in a of and in and samples were in resulting in were to and microarray were in protein and serum in for were for in protein and for in protein were for to and a of microarray sera in analyses of serum were in and used for were for M. M. M. a for microarray and were for of of for protein protein in resulting in for for a were against of fractions of in reactivity microarray for and Western of fractions of proteins of of for proteins in a Western blot of fractions were and to of Mycobacterium tuberculosis culture filtrate proteins two-dimensional and were in for and to sera from patients and control were for and were protein to that to patients’ sera Western were and to and resulting were of for of protein for were to a and of in a of a and were a of and a of of and used to of to protein that proteins. to and and to of and of that and and protein to from laboratories used to of proteins recognized patients’ sera of human to culture filtrate of Mycobacterium of in tuberculosis However, this methodology is not for of large of sera to of in and to high throughput a a large number of sera not to identify proteins to of disease M. to infection and a protein of not to protein microarray for a a that 960 native protein fractions of to in of recognized individuals of patients’ sera recognized a number of protein fractions sera of healthy and sera of patients noncavitary recognized a of fractions that to sera of patients cavitary disease. of reactivity Western blot three to to sera of healthy individuals and of cavitary proteins were recognized noncavitary patients’ sera of human to culture filtrate of Mycobacterium of in tuberculosis of a in of three disease states and fractions recognized and patients’ and were is that fractions were recognized noncavitary and cavitary patients’ that this is recognized early in disease of human to culture filtrate of Mycobacterium of culture filtrate of Mycobacterium Our analyses a of fractions recognized cavitary patients’ of fractions and recognized cavitary and noncavitary patients’ However, and were recognized cavitary patients’ that in cavitary and noncavitary of a cavitary that this is recognized patients disease of human to culture filtrate of Mycobacterium of culture filtrate of Mycobacterium to identify that noncavitary patients from stages of disease. this native protein fractions were noncavitary A in of fractions, that not noncavitary fractions were recognized of cavitary patients’ used to protein and protein were to for reactivity in three of fractions, and were in fractions recognized sera of cavitary a noncavitary and that of methodology used noncavitary patients’ sera a of recognized patients’ and were were a of human to culture filtrate of Mycobacterium of in tuberculosis to were of fractions of sera a to of that in this to and reactivity to patients’ to sera in and of tuberculosis in human immunodeficiency virus to of Mycobacterium of in tuberculosis However, microarray of patients’ sera that recognized fractions that sera from this of patients to of recognized noncavitary patients’ sera of in tuberculosis However, fractions reactivity to patients’ of fractions sera to a in for this A Western blot to a from and is recognized a in disease states of in tuberculosis native protein demonstrated that not fractions were from protein not a serological were protein that to patients’ sera were of in tuberculosis is that of protein to in is not to of and protein of a of and and for from to of protein to for of of and to to and M. of from Mycobacterium protein three and of to A to and in Mycobacterium of of proteins a A for a of Mycobacterium and of and to this protein three of of proteins a native and of proteins and is that for of culture filtrate of Mycobacterium M. of of Mycobacterium tuberculosis to in in M. tuberculosis a against of and to of of M. of Mycobacterium and for and for a protein that native protein of in this to a for of in of Mycobacterium and this that is in human disease. is recognized and of and a recognized in this M. M. and of protein in culture of Mycobacterium a of culture established a M. and of of Mycobacterium this protein of protein technology of of laboratories proteins and of proteins culture filtrate and for However, to for proteins of that a number of were in this of protein and for number of is that of from in and culture filtrate protein is protein of M. tuberculosis is for and in this a for this is that microarray technology is to a protein serological to proteins in human disease in this patients of in tuberculosis of in from in states of disease and reactivity of proteins in M. in of protein and to disease states for of proteins recognized cavitary and noncavitary patients’ sera and proteins that of cavitary from to and protein that not of of disease that of tuberculosis (TB) used culture filtrate human immunodeficiency M. protein purified protein used culture filtrate human immunodeficiency M. protein purified protein is and that is that of for a sensitive to control of a to of in in that to high of and and for of a for to disease and and patients coinfected human immunodeficiency virus from laboratories that provide high and used in of tuberculosis in human immunodeficiency virus to of Mycobacterium to of Mycobacterium of of human to culture filtrate of Mycobacterium of culture filtrate of Mycobacterium of serum and for diagnosis of of Mycobacterium tuberculosis recognized of Mycobacterium tuberculosis protein and this reactivity disease of tuberculosis in human immunodeficiency virus to of Mycobacterium of human to culture filtrate of Mycobacterium of culture filtrate of Mycobacterium of Mycobacterium tuberculosis recognized of Mycobacterium tuberculosis protein and of in tuberculosis However, a of patients’ serological reactivity to a large of Mycobacterium tuberculosis is to reactivity of proteins of in a high throughput protein for a M. M. A microarray for a for of and of protein for and serum a of from to of against of to and human for were in microarray of in and technology to microarray for to and virus M. to infection and thousands of a and for of to this methodology is and of sera from a large number of of a to a protein microarray native proteins were A separation to native proteins in cytosol and culture filtrate of in 960 protein fractions from protein fractions were to and sera from purified protein derivative-positive healthy cavitary noncavitary and and resulting analyses two-dimensional that a of is recognized early in disease proteins for cavitary patients were and were of from a to of culture in of Mycobacterium tuberculosis culture filtrate proteins two-dimensional and culture from and to generate culture filtrate proteins of of of of of Mycobacterium were three and of of in of and and a resulting of and for to cytosol of and M. of Mycobacterium and against a protein of cytosol and were protein of protein of and proteins of and proteins were 42 and and and respectively. proteins were for protein were in and of were against a and protein were of and and were to for fractions were to and to were a of of a of a protein fractions were and were and fractions of protein were fractions were fractions were to and to and proteins were of fractions were in a and in of and protein were Sera and from of individuals were of individuals were from is of Mycobacterium individuals were from and were not were of of patients disease of patients were individuals were to of of for were patients from in were to of for of patients were were of of patients from of patients of cavitary patients were to to of in of tuberculosis in human immunodeficiency virus to of Mycobacterium of culture filtrate of Mycobacterium patients were to of of for were individuals from sera were to to proteins to of Mycobacterium of and sera against proteins were from and of and were used for microarray analyses and and sera and of of to and in of protein were to and of to and a microarray proteins, native protein and fractions were in a of and in and samples were in resulting in were to and microarray were in protein and serum in for were for in protein and for in protein were for to and a of microarray sera in analyses of serum were in and used for were for M. M. M. a for microarray and were for of of for protein protein in resulting in for for a were against of fractions of in reactivity microarray for and Western of fractions of proteins of of for proteins in a Western blot of fractions were and to of Mycobacterium tuberculosis culture filtrate proteins two-dimensional and were in for and to sera from patients and control were for and were protein to that to patients’ sera Western were and to and resulting were of for of protein for were to a and of in a of a and were a of and a of of and used to of to protein that proteins. to and and to of and of that and and protein to of from a to of culture in of Mycobacterium tuberculosis culture filtrate proteins two-dimensional and culture from and to generate culture filtrate proteins of of of of of Mycobacterium were three and of of in of and and a resulting of and for to cytosol of and M. of Mycobacterium and against a protein of cytosol and were protein of protein from a to of culture in of Mycobacterium tuberculosis culture filtrate proteins two-dimensional and culture from and to generate culture filtrate proteins of of of of of Mycobacterium were three and of of in of and and a resulting of and for to cytosol of and M. of Mycobacterium and against a protein of cytosol and were protein of protein of and proteins of and proteins were 42 and and and respectively. proteins were for protein were in and of were against a and protein were of and and were to for fractions were to and to were a of of a of a protein fractions were and were and fractions of protein were fractions were fractions were to and to and proteins were of fractions were in a and in of and protein were of and proteins of and proteins were 42 and and and respectively. proteins were for protein were in and of were against a and protein were of and and were to for fractions were to and to were a of of a of a protein fractions were and were and fractions of protein were fractions were fractions were to and to and proteins were of fractions were in a and in of and protein were Sera and from of individuals were of individuals were from is of Mycobacterium individuals were from and were not were of of patients disease of patients were individuals were to of of for were patients from in were to of for of patients were were of of patients from of patients of cavitary patients were to to of in of tuberculosis in human immunodeficiency virus to of Mycobacterium of culture filtrate of Mycobacterium patients were to of of for were individuals from sera were to to proteins to of Mycobacterium of and sera against proteins were from and of and were used for microarray analyses and and sera Sera from of individuals were of individuals were from is of Mycobacterium individuals were from and were not were of of patients disease of patients were individuals were to of of for were patients from in were to of for of patients were were of of patients from of patients of cavitary patients were to to of in of tuberculosis in human immunodeficiency virus to of Mycobacterium of culture filtrate of Mycobacterium patients were to of of for were individuals from sera were to to proteins to of Mycobacterium of and sera against proteins were from and of and were used for microarray analyses and and sera of individuals were from is of Mycobacterium individuals were from and were not of individuals were from is of Mycobacterium individuals were from and were not were of of patients disease of patients were individuals were to of of for were of of patients disease of patients were individuals were to of of for were patients from in were to of for of patients were were patients from in were to of for of patients were were of of patients from of patients of cavitary patients were to to of in of tuberculosis in human immunodeficiency virus to of Mycobacterium of culture filtrate of Mycobacterium patients were to of of for were of of patients from of patients of cavitary patients were to to of in of tuberculosis in human immunodeficiency virus to of Mycobacterium of culture filtrate of Mycobacterium patients were to of of for were individuals from sera were to to proteins to of Mycobacterium of and sera against proteins were from and of and were used for microarray analyses and and sera were individuals from sera were to to proteins to of Mycobacterium of and sera against proteins were from and of and were used for microarray analyses and and sera and of of to and in of protein were to and of to and a microarray proteins, native protein and fractions were in a of and in and samples were in resulting in were to and microarray were in protein and serum in for were for in protein and for in protein were for to and a of microarray sera in analyses of serum were in and used for of of to and in of protein were to and of to and a microarray proteins, native protein and fractions were in a of and in and samples were in resulting in were to and microarray were in protein and serum in for were for in protein and for in protein were for to and a of microarray sera in analyses of serum were in and used for were for M. M. M. a for microarray and were for of of for protein protein in resulting in for for a were against of fractions of in reactivity microarray for were for M. M. M. a for microarray and were for of of for protein protein in resulting in for for a were against of fractions of in reactivity microarray for and Western of fractions of proteins of of for proteins in a Western blot of fractions were and to of Mycobacterium tuberculosis culture filtrate proteins two-dimensional and were in for and to sera from patients and control were for and were of fractions of proteins of of for proteins in a Western blot of fractions were and to of Mycobacterium tuberculosis culture filtrate proteins two-dimensional and were in for and to sera from patients and control were for and were protein to that to patients’ sera Western were and to and resulting were of for of protein for were to a and of in a of a and were a of and a of of and used to of to protein that proteins. to and and to of and of that and and protein to protein to that to patients’ sera Western were and to and resulting were of for of protein for were to a and of in a of a and were a of and a of of and used to of to protein that proteins. to and and to of and of that and and protein to from laboratories used to of proteins recognized patients’ sera of human to culture filtrate of Mycobacterium of in tuberculosis However, this methodology is not for of large of sera to of in and to high throughput a a large number of sera not to identify proteins to of disease M. to infection and a protein of not to protein microarray for a a that 960 native protein fractions of to in of recognized individuals of patients’ sera recognized a number of protein fractions sera of healthy and sera of patients noncavitary recognized a of fractions that to sera of patients cavitary disease. of reactivity Western blot three to to sera of healthy individuals and of cavitary proteins were recognized noncavitary patients’ sera of human to culture filtrate of Mycobacterium of in tuberculosis of a in of three disease states and fractions recognized and patients’ and were is that fractions were recognized noncavitary and cavitary patients’ that this is recognized early in disease of human to culture filtrate of Mycobacterium of culture filtrate of Mycobacterium Our analyses a of fractions recognized cavitary patients’ of fractions and recognized cavitary and noncavitary patients’ However, and were recognized cavitary patients’ that in cavitary and noncavitary of a cavitary that this is recognized patients disease of human to culture filtrate of Mycobacterium of culture filtrate of Mycobacterium to identify that noncavitary patients from stages of disease. this native protein fractions were noncavitary A in of fractions, that not noncavitary fractions were recognized of cavitary patients’ used to protein and protein were to for reactivity in three of fractions, and were in fractions recognized sera of cavitary a noncavitary and that of methodology used noncavitary patients’ sera a of recognized patients’ and were were a of human to culture filtrate of Mycobacterium of in tuberculosis to were of fractions of sera a to of that in this to and reactivity to patients’ to sera in and of tuberculosis in human immunodeficiency virus to of Mycobacterium of in tuberculosis However, microarray of patients’ sera that recognized fractions that sera from this of patients to of recognized noncavitary patients’ sera of in tuberculosis However, fractions reactivity to patients’ of fractions sera to a in for this A Western blot to a from and is recognized a in disease states of in tuberculosis native protein demonstrated that not fractions were from protein not a serological were protein that to patients’ sera were of in tuberculosis is that of protein to in is not to of and protein of a of and and for from to of protein to for of of and to to and M. of from Mycobacterium protein three and of to A to and in Mycobacterium of of proteins a A for a of Mycobacterium and of and to this protein three of of proteins a native and of proteins and is that for of culture filtrate of Mycobacterium M. of of Mycobacterium tuberculosis to in in M. tuberculosis a against of and to of of M. of Mycobacterium and for and for a protein that native protein of in this to a for of in of Mycobacterium and this that is in human disease. is recognized and of and a recognized in this M. M. and of protein in culture of Mycobacterium a of culture established a M. and of of Mycobacterium this protein of protein technology of of laboratories proteins and of proteins culture filtrate and for However, to for proteins of that a number of were in this of protein and for number of is that of from in and culture filtrate protein is protein of M. tuberculosis is for and in this a for this is that microarray technology is to a protein serological to proteins in human disease in this patients of in tuberculosis of in from in states of disease and reactivity of proteins in M. in of protein and to disease states for of proteins recognized cavitary and noncavitary patients’ sera and proteins that of cavitary from to and protein that not of of disease from laboratories used to of proteins recognized patients’ sera of human to culture filtrate of Mycobacterium of in tuberculosis However, this methodology is not for of large of sera to of in and to high throughput a a large number of sera not to identify proteins to of disease M. to infection and a protein of not to protein microarray for a a that 960 native protein fractions of to in of recognized individuals of patients’ sera recognized a number of protein fractions sera of healthy and sera of patients noncavitary recognized a of fractions that to sera of patients cavitary disease. of reactivity Western blot three to to sera of healthy individuals and of cavitary proteins were recognized noncavitary patients’ sera of human to culture filtrate of Mycobacterium of in tuberculosis of a in of three disease states and fractions recognized and patients’ and were is that fractions were recognized noncavitary and cavitary patients’ that this is recognized early in disease of human to culture filtrate of Mycobacterium of culture filtrate of Mycobacterium Our analyses a of fractions recognized cavitary patients’ of fractions and recognized cavitary and noncavitary patients’ However, and were recognized cavitary patients’ that in cavitary and noncavitary of a cavitary that this is recognized patients disease of human to culture filtrate of Mycobacterium of culture filtrate of Mycobacterium to identify that noncavitary patients from stages of disease. this native protein fractions were noncavitary A in of fractions, that not noncavitary fractions were recognized of cavitary patients’ used to protein and protein were to for reactivity in three of fractions, and were in fractions recognized sera of cavitary a noncavitary and that of methodology used noncavitary patients’ sera a of recognized patients’ and were were a of human to culture filtrate of Mycobacterium of in tuberculosis to were of fractions of sera a to of that in this to and reactivity to patients’ to sera in and of tuberculosis in human immunodeficiency virus to of Mycobacterium of in tuberculosis However, microarray of patients’ sera that recognized fractions that sera from this of patients to of recognized noncavitary patients’ sera of in tuberculosis However, fractions reactivity to patients’ of fractions sera to a in for this A Western blot to a from and is recognized a in disease states of in tuberculosis native protein demonstrated that not fractions were from protein not a serological were protein that to patients’ sera were of in tuberculosis is that of protein to in is not to of and protein of a of and and for from to of protein to for of of and to to and M. of from Mycobacterium protein three and of to A to and in Mycobacterium of of proteins a A for a of Mycobacterium and of and to this protein three of of proteins a native and of proteins and is that for of culture filtrate of Mycobacterium M. of of Mycobacterium tuberculosis to in in M. tuberculosis a against of and to of of M. of Mycobacterium and for and for a protein that native protein of in this to a for of in of Mycobacterium and this that is in human disease. is recognized and of and a recognized in this M. M. and of protein in culture of Mycobacterium a of culture established a M. and of of Mycobacterium this protein of protein technology of of laboratories proteins and of proteins culture filtrate and for However, to for proteins of that a number of were in this of protein and for number of is that of from in and culture filtrate protein is protein of M. tuberculosis is for and in this a for this is that microarray technology is to a protein Our serological to proteins in human disease in this patients of in tuberculosis of in from in states of disease and reactivity of proteins in M. in of protein and to disease states for of proteins recognized cavitary and noncavitary patients’ sera and proteins that of cavitary from to and protein that not of of disease for protein separation and for in

References

35